Cargando…
Novel ssDNA Ligand Against Ovarian Cancer Biomarker CA125 With Promising Diagnostic Potential
The in-vitro diagnostic industry is always striving to explore specific and high-affinity recognition entities, sensitive probes, and newer technology or platforms to develop disease detection methods with lower production and time costs and with minimum interference or variability. Aptamers suffice...
Autores principales: | Tripathi, Pranav, Sachan, Manisha, Nara, Seema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242751/ https://www.ncbi.nlm.nih.gov/pubmed/32500059 http://dx.doi.org/10.3389/fchem.2020.00400 |
Ejemplares similares
-
Comparative studies on the interaction of anticancer drug irinotecan with dsDNA and ssDNA
por: Temerk, Yassien, et al.
Publicado: (2018) -
Exosomal CA125 as A Promising Biomarker for Ovarian Cancer Diagnosis
por: Chen, Zhixiang, et al.
Publicado: (2020) -
Details of ssDNA annealing revealed by an HSV-1 ICP8–ssDNA binary complex
por: Tolun, Gökhan, et al.
Publicado: (2013) -
AuNP and ssDNA capped mesoporous silica nanoparticles for laser controlled drug release
por: Zhou, Lu, et al.
Publicado: (2019) -
Characterization of an SSB–dT25 complex: structural insights into the S-shaped ssDNA binding conformation
por: Huang, Yen-Hua, et al.
Publicado: (2019)